Skip to content
OpenCapital
Get started

Tarsus Pharmaceuticals, Inc. TARS Commercial Sales Milestone Payments — Contractual milestone payment net sales

Similar metrics at other companies

Zymeworks logo
ZYMECommercial Sales Milestones — Research and development collaborations (note 11)
$216.75M—
Exelixis logo
EXELLicense revenues — Revenue from contract with customer, commercial sales milestone
$5.3M+393%
Halozyme Therapeutics logo
HALOSales-based milestones — Revenue from Contract with Customer, Excluding Assessed Tax
$0-100%
Axsome Therapeutics logo
AXSMMilestone Revenue — Revenue
$500K—
Incyte logo
INCYMilestone and contract revenues — Total revenues
$17M—
Crinetics Pharmaceuticals logo
CRNXLicense — Milestone revenue
$1.5M—

Other financials

Income statement

See full
Revenue$162.1M+107%
Gross profit$152.7M+109%
Operating income-$6.1M+76.7%
Net income-$7.0M+72.3%
EPS (diluted)-$0.16+75.0%

Balance sheet

See full
Cash & equivalents$104.2M-41.6%
Total debt$88.7M+22.5%
Total equity$349.0M+1.9%
Total assets$581.1M+16.1%

Cash flow

See full
Operating cash flow-$24.7M-19.4%
CapEx$5.8M+886%
Free cash flow-$30.5M-43.4%

Valuation

See full
Market cap$2.85B+41.1%
Enterprise value$2.83B+47.8%
P/S5.3×-3.3×

Profitability

See full
Gross margin42.7%—
Operating margin-9.5%-4.2pp
Net margin-9%-4.0pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-14%-5.2pp
Debt / equity0.3×0.0×
Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept tars:CollaborativeArrangementRightsAndObligationsContractualMilestoneNetSales.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s commercial sales milestone payments — contractual milestone payment net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s commercial sales milestone payments — contractual milestone payment net sales?
Tarsus Pharmaceuticals, Inc. (TARS) reported commercial sales milestone payments — contractual milestone payment net sales of $102M in Q1 2026.
What does commercial sales milestone payments — contractual milestone payment net sales mean?
This metric represents the net revenue recognized from contractual milestone payments triggered by the achievement of specific commercial sales thresholds for a licensed therapeutic product. It reflects the successful market penetration and commercial performance of the company's pharmaceutical assets as defined by underlying licensing or collaboration agreements. Tracking this figure provides insight into the realization of contingent revenue streams tied to product adoption.